American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
35.87
+0.13 (0.36%)
Jun 20, 2025, 4:00 PM - Market closed
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 7 analysts that cover American Healthcare REIT stock have a consensus rating of "Strong Buy" and an average price target of $37.14, which forecasts a 3.54% increase in the stock price over the next year. The lowest target is $31 and the highest is $45.
Price Target: $37.14 (+3.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
Buy | 5 | 5 | 4 | 4 | 4 | 4 |
Hold | 1 | 1 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 6 | 7 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Keybanc | Keybanc | Buy Maintains $34 → $40 | Buy | Maintains | $34 → $40 | +11.51% | Jun 11, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $32 → $38 | Strong Buy | Maintains | $32 → $38 | +5.94% | Jun 9, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $37 → $45 | Buy | Maintains | $37 → $45 | +25.45% | May 20, 2025 |
Jefferies | Jefferies | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +3.15% | Apr 28, 2025 |
Keybanc | Keybanc | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | -5.21% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
2.23B
from 2.06B
Increased by 8.10%
Revenue Next Year
2.38B
from 2.23B
Increased by 6.50%
EPS This Year
0.36
from -0.29
EPS Next Year
0.67
from 0.36
Increased by 83.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.4B | 2.7B | 2.9B |
Avg | 2.2B | 2.4B | 2.6B |
Low | 2.1B | 2.2B | 2.4B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 17.0% | 19.8% | 23.7% |
Avg | 8.1% | 6.5% | 9.0% |
Low | 2.6% | -0.1% | -0.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.44 | 0.82 | 1.01 |
Avg | 0.36 | 0.67 | 0.95 |
Low | 0.26 | 0.47 | 0.90 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 125.2% | 51.2% |
Avg | - | 83.3% | 42.4% |
Low | - | 29.4% | 35.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.